Orthofix Medical (OFIX) Other Operating Expenses (2010 - 2026)

Orthofix Medical has disclosed Other Operating Expenses across 15 years of filings, most recently posting $2.9 million for Q1 2026.

• Quarterly Other Operating Expenses fell 4.14% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.9 million (down 126.27% YoY) and the FY2025 annual result came in at -$33.8 million, down 114.25% from the prior year.
• Other Operating Expenses advanced to $2.9 million in Q1 2026, from -$62.4 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $101.6 million in Q4 2022 and troughed at -$62.4 million in Q4 2025.
• A 5-year average of -$2.0 million and a median of $1.3 million in 2023 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2023 — Other Operating Expenses soared 4863.84% — and 2025, when it sank 139.22%.
• Tracing OFIX's Other Operating Expenses over 5 years: stood at $101.6 million in 2022, then tumbled by 119.75% to -$20.1 million in 2023, then plunged by 30.02% to -$26.1 million in 2024, then tumbled by 139.22% to -$62.4 million in 2025, then soared by 104.67% to $2.9 million in 2026.
• Business Quant data shows OFIX's Other Operating Expenses at $2.9 million in Q1 2026, -$62.4 million in Q4 2025, and $21.5 million in Q3 2025.